Recently, the newly developed drug tirzepatide, which targets both the GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptors, was introduced to the market to treat type 2 diabetes and obesity in 2022 and 2023, respectively (Table 1)
Advanced Spinal Decompression Therapy If you're experiencing back pain after weight loss, advanced spinal decompression therapy (SDT) might offer effective, non-invasive relief
That was the case this December, when the FDA approved an oral version of Wegovy, the first-ever oral GLP-1 medication specifically indicated for weight loss
[1] Healthcare providers may recommend diagnostic evaluation if bloating is atypical or concerning
- To identify over-the-counter products that can be supplied to support travellers visiting a pharmacy - Compare and contrast classes of over-the-counter products for selected conditions and identify/select appropriate patients for their use